|Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets|
B Van Hout, MF Janssen, YS Feng, T Kohlmann, J Busschbach, D Golicki, ...
Value in health 15 (5), 708-715, 2012
|Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study|
MF Janssen, AS Pickard, D Golicki, C Gudex, M Niewada, L Scalone, ...
Quality of Life Research 22 (7), 1717-1727, 2013
|Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group|
A Gringeri, LG Mantovani, L Scalone, PM Mannucci, COCIS Study Group
Blood 102 (7), 2358-2363, 2003
|Development of the EQ-5D-Y: a child-friendly version of the EQ-5D|
N Wille, X Badia, G Bonsel, K Burstr÷m, G Cavrini, N Devlin, AC Egmar, ...
Quality of life research 19 (6), 875-886, 2010
|Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study|
U Ravens-Sieberer, N Wille, X Badia, G Bonsel, K Burstr÷m, G Cavrini, ...
Quality of life research 19 (6), 887-897, 2010
|Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors|
L Scalone, LG Mantovani, PM Mannucci, A Gringeri, ...
Haemophilia 12 (2), 154-162, 2006
|Discrete choice modeling for the quantification of health states: the case of the EQ‐5D|
EA Stolk, M Oppe, L Scalone, PFM Krabbe
Value in health 13 (8), 1005-1013, 2010
|Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: the ITHACA study|
L Scalone, LG Mantovani, M Krol, D Rofail, S Ravera, M Grazia Bisconte, ...
Current medical research and opinion 24 (7), 1905-1917, 2008
|Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases|
L Scalone, R Ciampichini, S Fagiuoli, I Gardini, F Fusco, L Gaeta, ...
Quality of Life Research 22 (7), 1707-1716, 2013
|Italian population-based values of EQ-5D health states|
L Scalone, PA Cortesi, R Ciampichini, A Belisari, LS D’Angiolella, ...
Value in health 16 (5), 814-822, 2013
|Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients|
L Scalone, F Borghetti, G Brunori, BF Viola, B Brancati, L Sottini, ...
Nephrology Dialysis Transplantation 25 (3), 907-913, 2010
|Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis|
PA Cortesi, L Scalone, L D'Angiolella, A Belisari, F Fusco, I Olivieri, ...
Clinical and Experimental Rheumatology-Incl Supplements 30 (4), S126, 2012
|Cost‐effectiveness and cost‐utility analysis of spinal cord stimulation in patients with failed back surgery syndrome: results from the PRECISE study|
F Zucco, R Ciampichini, A Lavano, A Costantini, M De Rose, P Poli, ...
Neuromodulation: Technology at the Neural Interface 18 (4), 266-276, 2015
|Differences between patients’, physicians’ and pharmacists’ preferences for treatment products in haemophilia: a discrete choice experiment|
LG Mantovani, MS Monzini, PM Mannucci, L Scalone, M Villa, A Gringeri, ...
Haemophilia 11 (6), 589-597, 2005
|Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids|
PA Cortesi, L Scalone, A Belisari, D Bonamonte, SP Cannav˛, ...
Contact dermatitis 70 (3), 158-168, 2014
|The societal burden of chronic liver diseases: results from the COME study|
L Scalone, S Fagiuoli, R Ciampichini, I Gardini, R Bruno, L Pasulo, ...
BMJ open gastroenterology 2 (1), e000025, 2015
|Health related quality of life norm data of the Italian general population: results using the EQ-5D-3L and EQ-5D-5L instruments|
L Scalone, PA Cortesi, R Ciampichini, G Cesana, LG Mantovani
Epidemiology, biostatistics and public health 12 (3), 2015
|Patient preferences and willingness to pay for different options of anticoagulant therapy|
M Moia, LG Mantovani, M Carpenedo, L Scalone, MS Monzini, G Cesana, ...
Internal and emergency medicine 8 (3), 237-243, 2013
|Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)|
A Rocino, PA Cortesi, L Scalone, LG Mantovani, R Crea, A Gringeri, ...
Haemophilia 22 (1), 96-102, 2016
|Preferences of patients, their family caregivers and vascular surgeons in the choice of abdominal aortic aneurysms treatment options: the PREFER study|
G Faggioli, L Scalone, LG Mantovani, F Borghetti, A Stella, ...
European Journal of Vascular and Endovascular Surgery 42 (1), 26-34, 2011